Filters

Aqsa Mohammed Ditta, Ruqaiya Muhammad Naeem, Muhammad Mohsin Sami, Muhammad Abdul Rafey, Hunain Ali, Muhammad Waqar Amjad, Fahad Jahangir, Kehan Ali Rizvi, Fatima Mohammad, Husam Abu Dawood, Muhammad Suleman, Muhammad Nabeel Saddique

Journal of the International Association of Providers of AIDS Care 2026;25():23259582261475549

Full Text

Abstract

Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy.

C Hadigan, D Kamin, J Liebau, S Mazza, S Barrow, M Torriani, R Rubin, S Weise, A Fischman, S Grinspoon

American journal of physiology. Endocrinology and metabolism 2006;290(2):E289-98

Free Full Text

Abstract

HIV infection--a risk factor for osteoporosis.

Joegi Thomas, Sheelagh M Doherty

Journal of acquired immune deficiency syndromes (1999) 2003;33(3):281-91

Full Text

Abstract

Protease inhibitor-sparing simplified maintenance therapy: a need for perspective.

James Young, Manuel Battegay, Heiner C Bucher

The Journal of antimicrobial chemotherapy 2004;54(2):303-5

Full Text

Abstract

Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients.

Richard M Rutstein, Roy J Kim

Paediatric drugs 2010;12(3):187-99

Full Text

Abstract

Use of recombinant human growth hormone in HIV-associated lipodystrophy.

Christine Wanke, Elizabeth Burgess

Current opinion in infectious diseases 2005;18(1):17-24

Full Text

Abstract

Results: 1 – 15 / 126

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""HIV-Associated Lipodystrophy Syndrome""[mesh_terms]

HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies.

Update on metabolic issues in HIV patients.

Clinical Features and Management of Non-HIV-Related Lipodystrophy in Children: A Systematic Review.

Lipodystrophy in HIV: Evolving Challenges and Unresolved Questions.

Dietary habits and their association with metabolic abnormalities in human immunodeficiency virus-related lipodystrophy.

The role of nutrition in fat deposition and fat atrophy in patients with HIV.

Switching strategies to improve lipid profile and morphologic changes.

HIV-associated dyslipidaemia: pathogenesis and treatment.

The HIV-1/HAART associated metabolic syndrome - novel adipokines, molecular associations and therapeutic implications.

Efficacy and Safety of Tesamorelin in People Living With HIV (PLWH) With Lipodystrophy: A Systematic Review and Meta-Analysis.

Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy.

HIV infection--a risk factor for osteoporosis.

Protease inhibitor-sparing simplified maintenance therapy: a need for perspective.

Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients.

Use of recombinant human growth hormone in HIV-associated lipodystrophy.

Results for

""HIV-Associated Lipodystrophy Syndrome""[mesh_terms]